Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies
Clinical trial NCT03961555 · COMPLETED
Trial details
- NCT number
- NCT03961555
- Sponsor
- Synermore Biologics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-03
- Primary completion
- 2021-12-23
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.